ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hederos, C.
Right arrow Articles by Berg, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hederos, C.
Right arrow Articles by Berg, A

Archives of Disease in Childhood, Vol 75, 494-497, Copyright © 1996 by Archives of Disease in Childhood.


PAPERS

Epogam evening primrose oil treatment in atopic dermatitis and asthma

CA Hederos and A Berg
Paediatric Clinic, Health Centre, Gripen, Karlstad, Sweden.

Essential fatty acids are claimed to have positive effects in atopic diseases. In a double blind, placebo controlled, parallel group study 58 out of 60 children, with atopic dermatitis and the need for regular treatment with topical skin steroids, completed a 16 weeks' treatment period with either Epogam evening primrose oil or placebo capsules. Twenty two of these subjects also had asthma. The parents used diaries to record symptom scores and concomitant medication. Peak expiratory flow was measured and disease activity was monitored by the clinician every four weeks. The plasma concentrations of essential fatty acids increased significantly in the group treated with Epogam capsules. The study demonstrated significant improvements of the eczema symptoms but no significant difference was found between the placebo and the Epogam groups. No therapeutic effect was shown on asthma symptoms or fidget.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. J. van Gool, C. Thijs, C. J. Henquet, A. C van Houwelingen, P. C Dagnelie, J. Schrander, P. P. Menheere, and P. A van den Brandt
{gamma}-Linolenic acid supplementation for prophylaxis of atopic dermatitis--a randomized controlled trial in infants at high familial risk
Am. J. Clinical Nutrition, April 1, 2003; 77(4): 943 - 951.
[Abstract] [Full Text] [PDF]


Home page
Pediatr. Rev.Home page
P. Gardiner and K. J. Kemper
Herbs in Pediatric and Adolescent Medicine
Pediatr. Rev., February 1, 2000; 21(2): 44 - 57.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1996 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health